DNABW (Ginkgo Bioworks Holdings) Total Equity: $443.15 Mil (As of Mar. 2026)


DNABW Ginkgo Bioworks Holdings Inc DNABW
63 GF Score
Price $0.00
! 6 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Total Equity?

Ginkgo Bioworks Holdings DNABW 63 Total Equity is $443.15 Mil as of Mar. 2026. GuruFocus rates DNABW with a GF Score™ of 63/100. The stock has 6 warning signs investors should review.

Ginkgo Bioworks Holdings's total equity for the quarter that ended in Mar. 2026 was $443.15 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ginkgo Bioworks Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings Total Equity Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 1,567.38 1,736.28 1,097.15 716.06 508.59

Ginkgo Bioworks Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 647.43 612.95 559.78 508.59 443.15
DNABW
63GF Score
Ginkgo Bioworks Holdings Inc DNABW
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ginkgo Bioworks Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1119.696-611.106
=508.59

Ginkgo Bioworks Holdings's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1033.075-589.922
=443.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $443.15 Mil mean?
Ginkgo Bioworks Holdings (DNABW) has a Total Equity of $443.15 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Ginkgo Bioworks Holdings and its competitors.
Is Ginkgo Bioworks Holdings' Total Equity too high?
Ginkgo Bioworks Holdings' current Total Equity is $443.15 Mil. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Total Equity compare to CADL and CABA?
Ginkgo Bioworks Holdings' Total Equity of $443.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Ginkgo Bioworks Holdings and its competitors. Ginkgo Bioworks Holdings's current Total Equity is $443.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current Total Equity of $443.15 Mil. The current Total Equity is $443.15 Mil. Ginkgo Bioworks Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current Total Equity is $443.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USADNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
63GF Score

Get the complete analysis for DNABW

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price